• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels.

作者信息

Heaney Jennifer L J, Richter Alex, Bowcock Stella, Pratt Guy, Child J Anthony, Jackson Graham, Morgan Gareth, Turesson Ingemar, Drayson Mark T

机构信息

Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.

King's College Hospital NHS Trust, London, UK.

出版信息

Haematologica. 2020 Apr;105(4):e169-e171. doi: 10.3324/haematol.2019.224360. Epub 2019 Aug 8.

DOI:10.3324/haematol.2019.224360
PMID:31399530
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7109726/
Abstract
摘要

相似文献

1
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels.使用血清游离轻链比值和M蛋白水平的修订阈值排除骨髓瘤诊断。
Haematologica. 2020 Apr;105(4):e169-e171. doi: 10.3324/haematol.2019.224360. Epub 2019 Aug 8.
2
[Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].[多发性骨髓瘤诊断时免疫球蛋白重链/轻链对（Hevylite）与血清蛋白凝胶电泳及散射比浊检测结果的关系分析]
Cas Lek Cesk. 2015;154(6):292-302.
3
Benefits of new immunoglobulin-derived biomarkers for the diagnosis and follow-up of patients with dysglobulinemia.新型免疫球蛋白衍生生物标志物在诊断和随访球蛋白异常血症患者中的益处。
Ann Biol Clin (Paris). 2016 Oct 1;74(5):597-605. doi: 10.1684/abc.2016.1180.
4
Levels of uninvolved immunoglobulins predict clinical status and progression-free survival for multiple myeloma patients.未受累免疫球蛋白水平可预测多发性骨髓瘤患者的临床状态和无进展生存期。
Br J Haematol. 2016 Jul;174(1):81-7. doi: 10.1111/bjh.14026. Epub 2016 Mar 27.
5
Free light chain testing in follow-up of multiple myeloma.多发性骨髓瘤随访中的游离轻链检测
Clin Chem Lab Med. 2006;44(8):1044-6. doi: 10.1515/CCLM.2006.188.
6
[A simple procedure for the reliable determination of free L-chains in the serum].[一种可靠测定血清中游离L链的简单方法]
Folia Haematol Int Mag Klin Morphol Blutforsch. 1981;108(4):553-8.
7
Investigating the utility of saliva immunoglobulins for the detection of myeloma and using myeloma proteins to clarify partition between oral and systemic immunity.研究唾液免疫球蛋白在骨髓瘤检测中的应用，并利用骨髓瘤蛋白阐明口腔和全身免疫之间的分区。
Eur J Haematol. 2022 Jun;108(6):493-502. doi: 10.1111/ejh.13758. Epub 2022 Feb 28.
8
Role of serum free light chain assay in the detection of early relapse and prediction of prognosis after relapse in multiple myeloma patients treated upfront with novel agents.血清游离轻链检测在接受新型药物一线治疗的多发性骨髓瘤患者早期复发检测及复发后预后预测中的作用
Haematologica. 2017 Mar;102(3):e104-e107. doi: 10.3324/haematol.2016.154070. Epub 2016 Dec 1.
9
Heavy/light chain specific immunoglobulin ratios provides no additional information than serum proteins electrophoresis and immunofixation for the diagnosis and the follow-up of intact immunoglobulin multiple myeloma patients.对于完整免疫球蛋白多发性骨髓瘤患者的诊断及随访，重链/轻链特异性免疫球蛋白比率相较于血清蛋白电泳和免疫固定电泳并未提供更多信息。
Pathol Biol (Paris). 2015 Sep;63(4-5):215-21. doi: 10.1016/j.patbio.2015.06.001. Epub 2015 Aug 28.
10
Quantification by Ultrafiltration and Immunofixation Electrophoresis Testing for Monoclonal Serum Free Light Chains.用超滤和免疫固定电泳检测法对单克隆血清游离轻链进行定量分析。
Lab Med. 2020 Nov 2;51(6):592-600. doi: 10.1093/labmed/lmaa012.

引用本文的文献

1
Presenting Symptoms in Newly Diagnosed Myeloma, Relation to Organ Damage, and Implications for Symptom-Directed Screening: A Secondary Analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) Trial.新诊断骨髓瘤的症状表现、与器官损害的关系及对症状导向筛查的意义：骨髓瘤早期发病与死亡应对（TEAMM）试验的二次分析
Cancers (Basel). 2023 Jun 25;15(13):3337. doi: 10.3390/cancers15133337.
2
Monoclonal gammopathy of increasing significance: time to screen?意义不断增加的单克隆丙种球蛋白病：是否需要进行筛查？
Haematologica. 2023 Jun 1;108(6):1476-1486. doi: 10.3324/haematol.2022.281802.
3
Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study.诊断时血清游离轻链比值与多发性骨髓瘤早期肾损伤相关：一项病例系列真实世界研究
Biomedicines. 2022 Jul 10;10(7):1657. doi: 10.3390/biomedicines10071657.
4
A Cohort Study of Free Light Chain Ratio in Combination with Serum Protein Electrophoresis as a First-Line Test in General Practice.一项关于游离轻链比值联合血清蛋白电泳作为全科医疗一线检测方法的队列研究。
Cancers (Basel). 2022 Jun 14;14(12):2930. doi: 10.3390/cancers14122930.
5
Investigating the utility of saliva immunoglobulins for the detection of myeloma and using myeloma proteins to clarify partition between oral and systemic immunity.研究唾液免疫球蛋白在骨髓瘤检测中的应用，并利用骨髓瘤蛋白阐明口腔和全身免疫之间的分区。
Eur J Haematol. 2022 Jun;108(6):493-502. doi: 10.1111/ejh.13758. Epub 2022 Feb 28.

本文引用的文献

1
Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial.来那度胺维持治疗与观察用于初诊多发性骨髓瘤患者（Myeloma XI）：一项多中心、开放标签、随机、3 期临床试验。
Lancet Oncol. 2019 Jan;20(1):57-73. doi: 10.1016/S1470-2045(18)30687-9. Epub 2018 Dec 14.
2
Global Burden of Multiple Myeloma: A Systematic Analysis for the Global Burden of Disease Study 2016.多发性骨髓瘤全球负担：2016 年全球疾病负担研究的系统分析。
JAMA Oncol. 2018 Sep 1;4(9):1221-1227. doi: 10.1001/jamaoncol.2018.2128.
3
Diagnosis and monitoring for light chain only and oligosecretory myeloma using serum free light chain tests.使用血清游离轻链检测对仅轻链型和寡分泌型骨髓瘤进行诊断和监测。
Br J Haematol. 2017 Jul;178(2):220-230. doi: 10.1111/bjh.14753. Epub 2017 Jun 1.
4
Presenting Signs of Multiple Myeloma and the Effect of Diagnostic Delay on the Prognosis.多发性骨髓瘤的临床表现及诊断延迟对预后的影响。
J Am Board Fam Med. 2016 Nov 12;29(6):702-709. doi: 10.3122/jabfm.2016.06.150393.
5
Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool.开发一种快速定量的侧向流动测定法，用于同时测量血清κ和λ免疫球蛋白游离轻链（FLC）：一种新的床边 FLC 筛选工具的诞生。
Clin Chem Lab Med. 2017 Mar 1;55(3):424-434. doi: 10.1515/cclm-2016-0194.
6
Quantifying the risk of multiple myeloma from symptoms reported in primary care patients: a large case-control study using electronic records.通过初级保健患者报告的症状量化多发性骨髓瘤的风险：一项使用电子记录的大型病例对照研究。
Br J Gen Pract. 2015 Feb;65(631):e106-13. doi: 10.3399/bjgp15X683545.
7
Serum free light chains in patients with HIV infection: their association with markers of disease severity and antiretroviral use.HIV感染患者的血清游离轻链：它们与疾病严重程度标志物及抗逆转录病毒治疗使用情况的关联。
J Clin Pathol. 2015 Feb;68(2):148-53. doi: 10.1136/jclinpath-2014-202733. Epub 2014 Dec 1.
8
Comparison of cancer diagnostic intervals before and after implementation of NICE guidelines: analysis of data from the UK General Practice Research Database.比较 NICE 指南实施前后的癌症诊断间隔：来自英国全科医学研究数据库的数据分析。
Br J Cancer. 2014 Feb 4;110(3):584-92. doi: 10.1038/bjc.2013.791. Epub 2013 Dec 24.
9
Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden.意义未明的单克隆丙种球蛋白血症与淋巴和骨髓恶性肿瘤风险：瑞典 728 例患者 30 年随访结果。
Blood. 2014 Jan 16;123(3):338-45. doi: 10.1182/blood-2013-05-505487. Epub 2013 Nov 12.
10
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial.唑来膦酸对比氯膦酸在多发性骨髓瘤（MRC Myeloma IX）一线治疗中的应用：一项随机对照试验。
Lancet. 2010 Dec 11;376(9757):1989-99. doi: 10.1016/S0140-6736(10)62051-X. Epub 2010 Dec 3.